The burgeoning popularity of semaglutide , initially for diabetes , is creating significant buzz within the UK , prompting a notable shift in hormone trends. Access these medications remains a complex situation , with NHS provision currently limited and specialist practices offering prescriptions at a premium . Worries are being raised regarding re